Intuitive History
Intuitive has been advancing minimally invasive care since 1995 with the goal of helping physicians improve the lives of people around the world. As we move forward, we continue to invest in minimally invasive robotic-assisted surgical and bronchoscopy solutions that contribute to care teams’ goals of better patient care, greater efficiencies, and improved access to quality health care.
1995
Year Intuitive is founded
1999
Year Intuitive launches the first da Vinci surgical system in Europe
4
Number of generations of da Vinci systems
2024
Year Intuitive launches the da Vinci Single-Port system in Europe
1995-2004
From prototype to first install. The Intuitive story started in 1995 when bright minds with a common vision and the drive to do something completely new helped change the face of surgery. In 1999, we launched the first da Vinci surgical system in Europe. In the hands of experienced surgeons, our minimally invasive surgical system found applications—such as urology—rapidly expanding the opportunity for robotic-assisted surgery.
2005–2013
Going global. Our technology arrived on the global scene with clearances in new countries and a growing presence around the world. In 2006, we launched our second-generation da Vinci S surgical system in the United-States.
From 2009 to 2013, we saw rapid innovation to our instruments and accessories, services, and the launch of da Vinci Si—our third-generation system designed to enhance training and the overall surgeon experience.
2014-2024
Broadening adoption. The pace intensified with new products, increased customer adoption, and a growing team of global talent dedicated to our mission. The technology kept getting better as surgeons harnessed our fourth-generation systems: the da Vinci X, da Vinci Xi, and our first single-port system—da Vinci SP.
Our horizons expanded beyond surgery in 2023 when the Ion endoluminal system, a robotic-assisted bronchoscopy system designed to enhance the biopsy of suspicious lung nodules and aid pulmonologists in detecting lung cancer earlier, received CE marking.
Disclosures
Da Vinci X & Xi Surgical Systems
The Intuitive Surgical Endoscopic Instrument Control Systems (da Vinci X and da Vinci Xi Surgical Systems) are intended to assist in the accurate control of Intuitive Surgical Endoscopic Instruments during urologic surgical procedures, general laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general thoracoscopic surgical procedures, and trans-oral otolaryngology surgical procedures restricted to benign tumors and malignant tumors classified as T1 and T2, and for benign base of tongue resection procedures. The systems are indicated for adult and pediatric use (except for trans-oral otolaryngology surgical procedures). They are intended to be used by trained physicians in an operating room environment.
The da Vinci X and da Vinci Xi Surgical Systems are class IIb medical devices CE marked (CE 2460) under the European Medical Devices Directive (93/42/EEC), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
Da Vinci SP Surgical System
The da Vinci SP Surgical System is intended to assist in the accurate control of the da Vinci SP endoscope and instruments during minimally invasive endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast surgical procedures. The system is indicated for adult use. It is intended to be used by trained physicians in an operating room environment.
The da Vinci SP Surgical System is a class IIb medical devices CE marked (CE 2460) under the European Medical Devices Regulation (EU 2017/745), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
Ion Endoluminal System
The Ion Endoluminal System assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion Endoluminal System enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use.
The Flexision Biopsy Needle is used with the Ion Endoluminal System to biopsy tissue from a target area in the lung.
The PlanPoint Software uses patient CT scans to create a 3D plan of the lung and navigation pathways for use with the Ion Endoluminal System.
The Ion Endoluminal System, the Flexision Biopsy Needle and the PlanPoint Software are class IIa medical devices CE marked (CE 2460) under the European Medical Devices Regulation (EU 2017/745), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
Legal Notices
Individuals' outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or physician/surgeon experience.
Some products, features or technologies may not be available in all countries. Please contact your local Intuitive representative for product availability in your region. Refer to the product specific User Manual for indications, contraindications, warnings and other product information.